Systematic Review on the Safety of Physical Exercise in Hypertrophic Cardiomyopathy: Recommendations from the Brazilian Society of Cardiology
Authors:
- Ricardo SteinRSRicardo Stein
- Rodrigo Otávio Bougleux AlôRARodrigo Otávio Bougleux Alô
- Luiz Eduardo Fonteles RittLRLuiz Eduardo Fonteles Ritt
- Anderson Donelli da SilveiraASAnderson Donelli da Silveira
- Artur Haddad HerdyAHArtur Haddad Herdy
- Clea ColomboCCClea Colombo
- Cristiano Faria PisaniCPCristiano Faria Pisani
- Fabrício BragaFBFabrício Braga
- Frank NunesFNFrank Nunes
- Luciana SacilottoLSLuciana Sacilotto
- Marconi Gomes SilvaMSMarconi Gomes Silva
Open Access
- 1 January 2026
- journal article
- review article
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 123 (8)
Abstract
Background Although historically discouraged due to the risk of arrhythmias and sudden cardiac death (SCD), physical exercise (PE) may be safe and beneficial for individuals with hypertrophic cardiomyopathy (HCM). Objective To evaluate the association between PE and the incidence of mortality and arrhythmic events in adults with HCM, stratifying the analysis according to different types and intensities of exercise. Methods Systematic review of randomized clinical trials (RCTs) and observational studies identified in PubMed, Embase, and the Cochrane Library through December 2024. Studies including individuals exposed to different intensities of PE were eligible. Risk of bias was assessed using the RoB 2 and ROBINS-I tools, and certainty of evidence using GRADE. Recommendations were developed by an expert panel of the Brazilian Society of Cardiology. Results Eight studies (four RCTs and four observational studies; 9,744 participants) were included. None reported an increased risk of mortality or severe arrhythmic events associated with PE, even at moderate or vigorous intensities. Syncope was rare. Additionally, a Korean observational study involving more than 7,000 participants (mean age: 59 years) demonstrated reduced all-cause mortality with higher physical activity intensity (dose–response curve). In low-risk athletes, competitive sports were not associated with severe adverse events. The quality of evidence ranged from moderate to very low. Conclusion PE in HCM should be encouraged based on individualized assessment. In patients without high-risk criteria for SCD, benefits appear to outweigh risks. For higher-risk subgroups, recommendations are more cautious and based on expert consensus.Keywords
Funding Information
- SBC
This publication has 38 references indexed in Scilit:
- Causal Association Between Sedentary Behaviors and Health Outcomes: A Systematic Review and Meta-Analysis of Mendelian Randomization StudiesSports Medicine, 2024
- Hypertrophic Cardiomyopathy: A Brief OverviewThe American Journal of Cardiology, 2024
- Vigorous Exercise in Patients With Hypertrophic CardiomyopathyJAMA Cardiology, 2023
- Daily Step Count and All-Cause Mortality: A Dose–Response Meta-analysis of Prospective Cohort StudiesSports Medicine, 2021
- Effect of Moderate-Intensity Exercise Training on Peak Oxygen Consumption in Patients With Hypertrophic CardiomyopathyJAMA, 2017
- How Hypertrophic Cardiomyopathy Became a Contemporary Treatable Genetic Disease With Low MortalityJAMA Cardiology, 2016
- New Perspectives on the Prevalence of Hypertrophic CardiomyopathyJACC, 2015
- Physical Activity and Other Health Behaviors in Adults With Hypertrophic CardiomyopathyThe American Journal of Cardiology, 2013
- Introduction: Eligibility recommendations for competitive athletes with cardiovascular abnormalities—general considerationsJACC, 2005
- Task force 3: Hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapseJACC, 1994